Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Resseptor Therapeutics enhances the treatment of the immune system's ability to identify and respond to tissues, malignancies, and pathogens
Cambridge Raman Imaging is developing a microscope which uses graphene to modulate ultra-short pulses of light to diagnose cancer tumours.
Rethinking AI with Cognition as our Blueprint
Deep Render is developing the next generation of media compression algorithms.
Mantle8 develops natural hydrogen exploration technology focused on identifying and evaluating underground hydrogen reservoirs.
Kynos Therapeutics develops KMO inhibitors across key indications in inflammation, immunity, and metabolism.
Adludio is the AI-powered platform that delivers interactive mobile advertising.
Hypervision Surgical develops AI-powered hyperspectral imaging technology that provides tissue analysis and visualization during surgery.
First Light Fusion is an energy company that focuses on researching energy generation by inertial confinement fusion.
Storm Therapeutics develops small-molecule therapies that target RNA-modifying enzymes to treat cancer and other diseases.
SaaS workflow solution gives carers and custodians more time for hands on care where and when it’s needed most.
Inductosense is developing wireless, battery-free, sensors that can be permanently fixed.
Pulsiv develops world-leading electronic solutions for AC to DC Power Supplies and Solar Energy applications.
Diffblue is a developer of automated testing software that enhances Java development by automatically generating unit tests.
Canopus Networks delivers AI-driven network analytics to improve traffic classification and enhance user experience across networks.
Helio Display Materials offers foundational materials for the new wave of display innovation driven by color conversion.
Making 24/7 renewables a reality through Thermal Energy Storage.
IBEX X-ray detector technology adds materials information to silicon based detectors.
The new dimension in sound. Projecting immersive, steerable 3D audio using small arrays of speakers and advanced head tracking technologies.
OXCCU develops technology to convert carbon dioxide and hydrogen into synthetic fuels, chemicals, and biodegradable plastics.
AccelerComm is a semiconductor IP-core company specialising in channel coding solutions.
Lumai delivers fully optical computing for a quicker, smarter and more sustainable world.
Mixergy offer a cost-effective solution to save energy and facilitate more renewable power generation.
Intrinsic Semiconductor Technologies is established to developed silicon-oxide based RRAM technologies.
IP Group has invested in 125 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
IP Group's top investment sectors include Artificial Intelligence (AI), Health Care, Medical, Machine Learning, Renewable Energy. The firm invests across 48 different industry categories.
Among tracked funding rounds, Storm Therapeutics received $56.0M in a Series C round. IP Group's total known invested capital is $1.0B.
IP Group's average investment size is $11.3M across its portfolio of 125 companies.
Recent IP Group portfolio additions include Resseptor Therapeutics, Cambridge Raman Imaging, i14, Deep Render, Mantle8. These companies were founded in 2020 or later.